Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy.
University of Duisburg-Essen, Essen, Germany.
Thorsten D
TD
Poeppel
Ali
A
Yuece
Christian
C
Boy
Klaus A
KA
Metz
Elke
E
Kaminsky
Hartmut P
HP
Neumann
Sandra J
SJ
Rosenbaum
Klaus
K
Mann
Lars C
LC
Moeller
D000328:Adult; D005260:Female; D006801:Humans; D064847:Multimodal Imaging; D009154:Mutation; D009362:Neoplasm Metastasis; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010235:Paraganglioma / Q000235:genetics* / Q000532:radiotherapy / Q000556:secondary; D049268:Positron-Emission Tomography; D013385:Succinate Dehydrogenase / Q000235:genetics*; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000473:pathology / Q000532:radiotherapy; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
C491545:SDHD protein, human; D015021:Yttrium Radioisotopes; C496730:90Y-octreotide, DOTA-Tyr(3)-; D013385:Succinate Dehydrogenase; D015282:Octreotide